Astrana Health, Inc. (ASTH) — Analyst outlook / Analyst consensus target is. Based on 9 analyst ratings, the consensus is bullish — 8 Buy, 1 Hold.
The consensus price target is $32.75 (low: $26.00, high: $40.00), representing an upside of 12.7% from the current price $29.07.
Analysts estimate Earnings Per Share (EPS) of $1.14 and revenue of $1.99B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.90 vs est $1.14 (missed -20.8%). 2025: actual $0.46 vs est $0.49 (missed -6.6%). Analyst accuracy: 83%.
ASTH Stock — 12-Month Price Forecast
$32.75
▲ +12.66% Upside
Average Price Target
Based on 9 Wall Street analysts offering 12-month price targets for Astrana Health, Inc., the average price target is $32.75, with a high forecast of $40.00, and a low forecast of $26.00.
The average price target represents a +12.66% change from the last price of $29.07.
Highest Price Target
$40.00
Average Price Target
$32.75
Lowest Price Target
$26.00
ASTH Analyst Ratings
Buy
Based on 9 analysts giving stock ratings to Astrana Health, Inc. in the past 3 months
EPS Estimates — ASTH
83%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.90
vs Est $1.14
▼ 26.2% off
2025
Actual $0.46
vs Est $0.49
▼ 7.1% off
Profitability Outlook
Company is profitable but with thin earnings per share. EPS trend is declining. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — ASTH
98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $2.035B
vs Est $1.987B
▲ 2.4% off
2025
Actual $3.182B
vs Est $3.161B
▲ 0.6% off
Revenue Trend
Strong revenue growth over the period shown. Analysts forecast revenue contraction ahead.
